Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors
Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors
Recruiting · NCT05870423 · Registry updated 2025-06-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Improving Peptide Receptor Radionuclide Therapy With PARP Inhibitors | Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor | Recruiting | Phase 1 | 2025-06-05 | NCT05870423 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Erasmus Medical Center | 271 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Erasmus MC | Rotterdam | Netherlands | 2 |